Doxazosin Tablets, USP 4 mg
Unichem is recalling Doxazosin Tablets 4 mg (NDC 29300-353-10) due to incorrect tablet imprinting that may cause medication errors.
Stop using this medication and contact your pharmacy or healthcare provider immediately to verify your bottle's imprint and obtain a correctly labeled replacement.
Recall at a glance
- Quantity recalled
- 60,000 tablets
Why it was recalled
Unichem Pharmaceuticals is recalling Doxazosin Tablets, USP, 4 mg (NDC 29300-353-10, 1000 tablets per bottle) distributed nationwide because some tablets are imprinted with incorrect identification markings, creating a risk of medication errors. Affected bottles were manufactured by Unichem Laboratories Limited in Goa, India.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Doxazosin Tablets, USP
- Strength
- 4 mg
- NDC / UPC
- NDC 29300-353-10
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other recent recalls from Unichem Pharmaceuticals USA Inc.
Editorial summary by Recall Canary · summary updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification